Page last updated: 2024-08-23

daunorubicin and l 685458

daunorubicin has been researched along with l 685458 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Bekaert, S; Cools, J; De Keersmaecker, K; Folens, C; Lahortiga, I; Marynen, P; Mentens, N; Odero, MD; Van Neste, L; Vandenberghe, P	1

Other Studies

2 other study(ies) available for daunorubicin and l 685458

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica, 2008, Volume: 93, Issue:4 Topics: Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzamides; Benzodiazepinones; Carbamates; Cell Cycle; Cell Division; Cell Line, Tumor; Daunorubicin; Dexamethasone; Dipeptides; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia-Lymphoma, Adult T-Cell; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Notch1; Sequence Analysis, DNA; Vincristine	2008

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.

Haematologica, 2008, Volume: 93, Issue:4

Topics: Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzamides; Benzodiazepinones; Carbamates; Cell Cycle; Cell Division; Cell Line, Tumor; Daunorubicin; Dexamethasone; Dipeptides; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia-Lymphoma, Adult T-Cell; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Notch1; Sequence Analysis, DNA; Vincristine

2008